Danaher Co. (NYSE:DHR) Shares Purchased by Channing Global Advisors LLC

Channing Global Advisors LLC lifted its holdings in Danaher Co. (NYSE:DHR) by 42.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,666 shares of the conglomerate’s stock after purchasing an additional 1,698 shares during the quarter. Danaher comprises about 0.9% of Channing Global Advisors LLC’s portfolio, making the stock its 25th biggest position. Channing Global Advisors LLC’s holdings in Danaher were worth $1,301,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Wedge Capital Management L L P NC boosted its position in shares of Danaher by 3.2% in the 3rd quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 38 shares in the last quarter. Meridian Financial Partners LLC boosted its position in shares of Danaher by 4.4% in the 3rd quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 40 shares in the last quarter. Kovack Advisors Inc. boosted its position in shares of Danaher by 3.4% in the 3rd quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after purchasing an additional 41 shares in the last quarter. Well Done LLC boosted its position in shares of Danaher by 1.2% in the 3rd quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock worth $987,000 after purchasing an additional 42 shares in the last quarter. Finally, Waypoint Capital Advisors LLC raised its stake in Danaher by 0.9% in the 3rd quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after acquiring an additional 42 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on DHR. Robert W. Baird reduced their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. KeyCorp raised their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, Barclays reduced their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of Danaher stock opened at $201.15 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $199.75 and a twelve month high of $281.70. The business has a 50-day moving average price of $231.17 and a 200 day moving average price of $250.62. The firm has a market cap of $145.29 billion, a PE ratio of 38.10, a P/E/G ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business posted $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.54%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.